Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | neuropeptide Y receptor Y1 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | follicle stimulating hormone receptor | neuropeptide Y receptor Y1 | 384 aa | 345 aa | 22.0 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | lipoxygenase | 0.0272 | 0.5789 | 0.7589 |
Plasmodium vivax | multidomain scavenger receptor, putative | 0.0071 | 0 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.0179 | 0.3108 | 0.4074 |
Brugia malayi | follicle stimulating hormone receptor | 0.0279 | 0.5983 | 0.7843 |
Schistosoma mansoni | lipoxygenase | 0.0145 | 0.2146 | 0.2814 |
Echinococcus granulosus | epidermal growth factor receptor | 0.0181 | 0.3163 | 0.4145 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.0336 | 0.7629 | 1 |
Loa Loa (eye worm) | TK/EGFR protein kinase | 0.0336 | 0.7629 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.0181 | 0.3163 | 0.4145 |
Echinococcus multilocularis | insulin receptor | 0.0107 | 0.1061 | 0.139 |
Echinococcus granulosus | insulin receptor | 0.0107 | 0.1061 | 0.139 |
Schistosoma mansoni | tyrosine kinase | 0.0107 | 0.1061 | 0.139 |
Schistosoma mansoni | tyrosine kinase | 0.0179 | 0.3108 | 0.4074 |
Echinococcus granulosus | melanoma receptor tyrosine protein kinase | 0.0181 | 0.3163 | 0.4145 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.0181 | 0.3163 | 0.4145 |
Echinococcus granulosus | insulin growth factor 1 receptor beta | 0.0107 | 0.1061 | 0.139 |
Brugia malayi | Protein kinase domain containing protein | 0.0107 | 0.1061 | 0.139 |
Plasmodium falciparum | LCCL domain-containing protein | 0.0071 | 0 | 0.5 |
Echinococcus multilocularis | 3 hydroxyacyl coenzyme A dehydrogenase type 2 | 0.0073 | 0.0071 | 0.0093 |
Leishmania major | 3-oxoacyl-(acyl-carrier protein) reductase, putative | 0.0073 | 0.0071 | 0.5 |
Echinococcus multilocularis | insulin growth factor 1 receptor beta | 0.0107 | 0.1061 | 0.139 |
Loa Loa (eye worm) | follicle stimulating hormone receptor | 0.0279 | 0.5983 | 0.7843 |
Onchocerca volvulus | 0.0071 | 0 | 0.5 | |
Schistosoma mansoni | 3-hydroxyacyl-CoA dehydrogenase | 0.0073 | 0.0071 | 0.0093 |
Schistosoma mansoni | tyrosine kinase | 0.0181 | 0.3163 | 0.4145 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.0272 | 0.5789 | 0.7589 |
Onchocerca volvulus | 0.0071 | 0 | 0.5 | |
Mycobacterium ulcerans | ATP phosphoribosyltransferase | 0.0419 | 1 | 1 |
Loa Loa (eye worm) | TK/INSR protein kinase | 0.0107 | 0.1061 | 0.139 |
Echinococcus granulosus | 3 hydroxyacyl coenzyme A dehydrogenase type 2 | 0.0073 | 0.0071 | 0.0093 |
Schistosoma mansoni | tyrosine kinase | 0.0336 | 0.7629 | 1 |
Mycobacterium tuberculosis | ATP phosphoribosyltransferase HisG | 0.0419 | 1 | 1 |
Brugia malayi | Furin-like cysteine rich region family protein | 0.0336 | 0.7629 | 1 |
Brugia malayi | 3-hydroxyacyl-CoA dehydrogenase type II | 0.0073 | 0.0071 | 0.0093 |
Echinococcus multilocularis | 0.0104 | 0.0964 | 0.1264 | |
Echinococcus granulosus | epidermal growth factor receptor | 0.0336 | 0.7629 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.0107 | 0.1061 | 0.139 |
Echinococcus granulosus | arachidonate 5 lipoxygenase | 0.0272 | 0.5789 | 0.7589 |
Schistosoma mansoni | tyrosine kinase | 0.0179 | 0.3108 | 0.4074 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 0.4 uM | In vitro binding affinity towards human neuropeptide Y receptor type 1, determined by measuring its ability to displace [125]peptide YY | ChEMBL. | 9667962 |
Ki (binding) | = 0.4 uM | In vitro binding affinity towards human neuropeptide Y receptor type 1, determined by measuring its ability to displace [125]peptide YY | ChEMBL. | 9667962 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.